Navigation Links
Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

products or product candidates; -- the Company's ability to enter into and successfully execute license and collaborative agreements, if any; -- the adequacy of the Company's capital resources and cash flow projections, and the Company's ability to obtain sufficient financing to maintain the Company's planned operations; -- the adequacy of the Company's patents and proprietary rights; -- the impact of litigation that has been brought against the Company and its officers and directors and any proposed settlement of such litigation; -- the Company's ability to regain compliance with the NASDAQ's listing qualifications, or its ability to successfully appeal the NASDAQ delisting; and -- the other risks described under Certain Risks and Uncertainties Related to the Company's Business, as contained in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

     CONTACT:

     For Genta Incorporated

     Tara Spiess/Andrea Romstad

     TS Communications Group, LLC

     (908) 286-3980

     

info@genta.com

CONTACT: Tara Spiess or Andrea Romstad, both of TS Communications Group,LLC, +1-908-286-3980, , for Genta Incorporated info@genta.com

Web site: http://www.genta.com/http://www.idispharma.com/http://www.genta.com//

Ticker Symbol: (NASDAQ-NMS:GNTA)


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/27/2014)... Research and Markets  has announced the ... 2014" report to their offering. ... professional and in-depth study on the current state of ... provides a basic overview of the industry including definitions, ... market analysis is provided for the international markets including ...
(Date:8/27/2014)... 27, 2014 Decision Resources Group finds that ... Memphis health system and hospital sector ... with rivals Methodist Le Bonheur Healthcare and Baptist Memorial ... coordinate patient care. In addition, a national contract recently ... health plan enrollment in the Memphis ...
(Date:8/27/2014)... 27, 2014 ResearchMoz presents this ...  Laparoscopes Market Outlook to 2020. New report, "United States ... on the United States Laparoscopes market . The ... (in units) and average prices (in US dollars) within ... Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid ...
Breaking Medicine Technology:Global Pulse Oximeter Industry Report 2014 2Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... a pre-clinical study of,leconotide, an investigative calcium channel blocker, ... efficacious as a new non-opioid treatment,for pain relief. ... nasal spray, transdermal patch, and pills. Data were ... Annual Meeting. , In the ...
... Jan. 28 Today at the American Academy of ... California at,San Diego report that no standardized practices ... Researchers looked at many factors,including: which steroids were ... a local anesthetic was mixed with the steroid. , ...
Cached Medicine Technology:Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 2Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment 3Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2
(Date:8/27/2014)... Lee Antimicrobial Solutions LLC (“LAMS”), ... Technology and a Leader in Environmental Disinfection Device ... a device developed for home use available for ... unveiled DHP Technology, a revolutionary means to disinfect ... of bacteria, viruses, microbes and offensive odors. A ...
(Date:8/27/2014)... New York, New York (PRWEB) August 27, 2014 ... to be filed in U.S. courts on behalf of ... due to uterine morcellation, Bernstein Liebhard LLP reports. According ... was filed on August 18th in the U.S. District ... a hysterectomy patient who claims the use of a ...
(Date:8/27/2014)... Austin, TX (PRWEB) August 27, 2014 Picture, ... no, not Holmes and Watson but more of a Mr. ... Glenn Davis, in terms of personalities and world view. This ... The University of Texas at Austin, and Mr. Outside was ... professor’s family physician, his new girlfriend, and a gaggle of ...
(Date:8/27/2014)... When Jagger was 20 years old and at university, he ... credits as one of the most memorable phone calls he ... set him up with a summer job; one working at ... and he has now spent the past 22 year working ... worked in school boards, employment programs and youth homeless shelters. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The newest ... PA on Monday, September 8, 2014. This new 15,000 ... that features three primary care practices and walk-in laboratory ... is a very exciting endeavor for Abington Health as ... and CEO, Abington Health. “Establishing a location in Lower ...
Breaking Medicine News(10 mins):Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 2Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Abington Health Opens New Health Center in Lower Gwynedd 2
... ... Swine Flu , ... (PRWEB) October 21, 2009 – As British Columbians face another wave of H1N1 this fall, ... and preventative tips in order to reduce the impact on campus life., , , , ...
... Philip O. Katz, MD, FACG, was elected by the ... of Gastroenterology (ACG), a national specialty association representing more ... diseases. Dr. Katz will officially take his position ... held next week in San Diego. In this ...
... of the world,s preeminent gastroenterologists will gather for ... Meeting at the San Diego Convention Center starting Monday, ... in gastrointestinal research, treatment of digestive diseases and clinical ... focus on new technologies being developed to diagnose and ...
... A new tasty citrus-flavored vitamin drink is now being offered ... immune systems a healthy boost* this Fall. , Emergen-C ... and convenient way to get a concentrated boost of immune-strengthening ... the original Emergen-C (®) ( )formula, containing 1,000 ...
... Nation to Aid Domestic Hunger , CHICAGO, Oct. 21 ... today announced that they have received a donation of 10 ... was made possible by a partnership between Macy,s and Feeding ... The "Come Together" campaign urged the public to donate to ...
... Red Mango, the fastest-growing retailer of all-natural nonfat frozen ... in Atlanta as part of an aggressive national expansion campaign. ... "Hot Concepts!" award, the company plans to open some 20 ... "We,re experiencing the strongest franchise growth in our company,s history, ...
Cached Medicine News:Health News:UCW Academy of Health Preps to Combat Spread of H1N1 2Health News:Dr. Philip Katz Elected President of the American College of Gastroenterology 2Health News:Dr. Philip Katz Elected President of the American College of Gastroenterology 3Health News:New Advances and Insights in Gastroenterology Presented at College's 74th Annual Meeting 2Health News:New Advances and Insights in Gastroenterology Presented at College's 74th Annual Meeting 3Health News:New Advances and Insights in Gastroenterology Presented at College's 74th Annual Meeting 4Health News:New Advances and Insights in Gastroenterology Presented at College's 74th Annual Meeting 5Health News:New Advances and Insights in Gastroenterology Presented at College's 74th Annual Meeting 6Health News:New Quick and Convenient Emergen-C(R) Shot Gives Immune Systems a Fighting Chance This Fall 2Health News:New Quick and Convenient Emergen-C(R) Shot Gives Immune Systems a Fighting Chance This Fall 3Health News:Macy's 'Come Together' Campaign Raises 10 Million Meals for Feeding America Food Banks 2Health News:Red Mango to Award Franchises in Atlanta 2
... of hypertensive and hopotensive patients by ... associated with blood pressure monitoring conducted ... user-friendly, one-step instrument, it enables physicians ... from the comfort of ther patient's ...
... For General Practitioners (GP'S) or ... by phone to a cardiac ... seconds per lead and 10 ... rhythm lead. Sequentially transmits 12 ...
The most compact revolutionary innovation in hematology. Automated and fully-integrated slide preparation and staining system....
... MGS-2 Mini-Ganzfeld stimulator is a portable visual ... your existing visual electrodiagnostic test system. Using ... the smallest commercial Ganzfeld to meet the ... Clinical Electrophysiology of Vision (ISCEV). The stimulator ...
Medicine Products: